APA
von Klot C. A., Kuczyk M. A., Boeker A., Reuter C., Imkamp F., Herrmann T. R. W., Tezval H., Kramer M. W., Perner S. & Merseburger A. S. (2017). Role of free testosterone levels in patients with metastatic castration-resistant prostate cancer receiving second-line therapy. : Oncology letters.
Chicago
von Klot Christoph A, Kuczyk Markus A, Boeker Alena, Reuter Christoph, Imkamp Florian, Herrmann Thomas R W, Tezval Hossein, Kramer Mario W, Perner Sven and Merseburger Axel S. 2017. Role of free testosterone levels in patients with metastatic castration-resistant prostate cancer receiving second-line therapy. : Oncology letters.
Harvard
von Klot C. A., Kuczyk M. A., Boeker A., Reuter C., Imkamp F., Herrmann T. R. W., Tezval H., Kramer M. W., Perner S. and Merseburger A. S. (2017). Role of free testosterone levels in patients with metastatic castration-resistant prostate cancer receiving second-line therapy. : Oncology letters.
MLA
von Klot Christoph A, Kuczyk Markus A, Boeker Alena, Reuter Christoph, Imkamp Florian, Herrmann Thomas R W, Tezval Hossein, Kramer Mario W, Perner Sven and Merseburger Axel S. Role of free testosterone levels in patients with metastatic castration-resistant prostate cancer receiving second-line therapy. : Oncology letters. 2017.